Patents Examined by Lei Yaolei Yao
  • Squamous cell carcinoma antigen-derived peptide binding to HLA-A24 molecule
    Patent number: 8030443
    Abstract: Provided is a squamous cell carcinoma antigen derived peptide which is capable of binding to an HLA-A24 molecule and recognized by the cellular immune system, and a pharmaceutical composition comprising said peptide for the treatment or prevention of squamous cell carcinoma.
    Type: Grant
    Filed: July 27, 2006
    Date of Patent: October 4, 2011
    Assignee: Kurume University
    Inventors: Kyogo Itoh, Mamoru Harada